With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Surface-ome of Embryonal Brain Tumors||Institut Curie / Olivier Ayrault, PhD||Crazy 8 Initiative||2019|
|Targeting Fusion-driven Sarcomas||National Institutes of Health / Javed Khan, MD||Crazy 8 Initiative||2019||Maryland|
|Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors||University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD||Young Investigator Grants||2019||Ontario|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||The Board of Trustees of the Leland Stanford Junior University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Targeting Valine-Specific Amino Acid Dependency -in T-Cell Acute Lymphoblastic Leukemia||New York University Medical Center / Palaniraja Thandapani, PhD||Young Investigator Grants||2019||New York|
|Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma||Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, MD||Innovation Grants||2019||Illinois|
|Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs||University of Alberta / Hasan Uludag, PhD, Joseph Brandwein, PhD & Xiaoyan Jiang, MD/PhD||Innovation Grants||2019||Alberta|
|Therapeutic Targeting of the Disrupted Metabolic State in DIPG||The Regents of the University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, PhD||Innovation Grants||2019||Michigan|